-
Story
Addressing unmet needs for inherited neuromuscular diseases -
Story
A legacy of blood cancer innovation -
Story
A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis -
Story
How collaboration can enhance your science career -
Media Release
Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
-
Story
A scientist from the start – Q&A with NIBR President Fiona Marshall -
Story
The art of drug design in a technological age -
Story
Stopping this coronavirus – and the next one -
Media Release
Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19
-
Media Release
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
-
Story
The future of chronic myeloid leukemia is evolving -
Story
Striving to vanquish leukemia